CardiAQ Valve Technologies Secures $37,300,000 Series B Funding

  • Feed Type
  • Date
    11/29/2012
  • Company Name
    CardiAQ Valve Technologies
  • Mailing Address
    2 Jenner Irvine, CA 92618
  • Company Description
    CardiAQ Valve Technologies (CVT), a privately held company founded by heart surgeon Dr. Arshad Quadri, is developing innovative approaches to heart valve replacement and is initially focused on percutaneous mitral valve replacement (PMVR).
  • Website
    http://www.cardiaq.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $37,300,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The funding, which incorporates conversion of a 2011 bridge financing, will be used to further validate the Company’s TMVI technology and is expected to carry the Company through its feasibility and CE mark clinical trials.
  • M&A Terms
  • Venture Investor
    OrbiMed Advisors
  • Venture Investor
    OrbiMed Advisors
  • Venture Investor
    Versant Ventures
  • Venture Investor
    Advent Healthcare Ventures

By posting a comment, you agree to our terms and conditions.